Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis

Delphine Bachelet, Signe Hässler, Cyprien Mbogning, Jenny Link, Malin Ryner, Ryan Ramanujam, Michael Auer, Poul Erik Hyldgaard Jensen, Nils Koch-Henriksen, Clemens Warnke, Kathleen Ingenhoven, Dorothea Buck, Verena Grummel, Andy Lawton, Naoimh Donnellan, Agnès Hincelin-Mery, Dan Sikkema, Marc Pallardy, Bernd Kieseier, Bernard Hemmer, Hans Peter Hartung, Per Soelberg Sorensen, Florian Deisenhammer, Pierre Dönnes, Julie Davidson, Anna Fogdell-Hahn, Philippe Broët, Unknown

Open source

DOI
10.1371/journal.pone.0162752
Published
2016-11-02
Container
PLOS ONE
Publisher
Public Library of Science (PLoS)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0162752,
  title = {Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis},
  author = {Delphine Bachelet and Signe Hässler and Cyprien Mbogning and Jenny Link and Malin Ryner and Ryan Ramanujam and Michael Auer and Poul Erik Hyldgaard Jensen and Nils Koch-Henriksen and Clemens Warnke and Kathleen Ingenhoven and Dorothea Buck and Verena Grummel and Andy Lawton and Naoimh Donnellan and Agnès Hincelin-Mery and Dan Sikkema and Marc Pallardy and Bernd Kieseier and Bernard Hemmer and Hans Peter Hartung and Per Soelberg Sorensen and Florian Deisenhammer and Pierre Dönnes and Julie Davidson and Anna Fogdell-Hahn and Philippe Broët and Unknown},
  year = {2016},
  journal = {PLOS ONE},
  doi = {10.1371/journal.pone.0162752},
  url = {https://doi.org/10.1371/journal.pone.0162752}
}

RIS

TY  - JOUR
TI  - Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis
AU  - Delphine Bachelet
AU  - Signe Hässler
AU  - Cyprien Mbogning
AU  - Jenny Link
AU  - Malin Ryner
AU  - Ryan Ramanujam
AU  - Michael Auer
AU  - Poul Erik Hyldgaard Jensen
AU  - Nils Koch-Henriksen
AU  - Clemens Warnke
AU  - Kathleen Ingenhoven
AU  - Dorothea Buck
AU  - Verena Grummel
AU  - Andy Lawton
AU  - Naoimh Donnellan
AU  - Agnès Hincelin-Mery
AU  - Dan Sikkema
AU  - Marc Pallardy
AU  - Bernd Kieseier
AU  - Bernard Hemmer
AU  - Hans Peter Hartung
AU  - Per Soelberg Sorensen
AU  - Florian Deisenhammer
AU  - Pierre Dönnes
AU  - Julie Davidson
AU  - Anna Fogdell-Hahn
AU  - Philippe Broët
AU  - Unknown
PY  - 2016
JO  - PLOS ONE
DO  - 10.1371/journal.pone.0162752
UR  - https://doi.org/10.1371/journal.pone.0162752
ER  - 

APA

Bachelet, D., Hässler, S., Mbogning, C., Link, J., Ryner, M., Ramanujam, R., Auer, M., Jensen, P. E. H., Koch-Henriksen, N., Warnke, C., Ingenhoven, K., Buck, D., Grummel, V., Lawton, A., Donnellan, N., Hincelin-Mery, A., Sikkema, D., Pallardy, M., Kieseier, B., Hemmer, B., Hartung, H. P., Sorensen, P. S., Deisenhammer, F., Dönnes, P., Davidson, J., Fogdell-Hahn, A., Broët, P., & Unknown (2016). Occurrence of Anti-Drug Antibodies against Interferon-Beta and Natalizumab in Multiple Sclerosis: A Collaborative Cohort Analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0162752

Source records